MedTrace Logo

To Access the Effect of Brain Pill™ on Working Memory Capacity and Mood Behaviour.

NCT03198936 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-04-12

No results posted yet for this study

Summary

Brain Pill™ is a mental health enhancing and successfully marketed dietary supplement.

Conditions

  • Memory Dysfunction
  • Mood Disorders

Interventions

DIETARY_SUPPLEMENT

Cognizin® SynapsaTM

2 capsules to be taken twice a day with meals with a glassful of water

DIETARY_SUPPLEMENT

Placebo

2 capsules to be taken twice a day with meals with glassful of water

Sponsors & Collaborators

  • Leading Edge Marketing LTD.

    collaborator UNKNOWN

  • Vedic Lifesciences Pvt. Ltd.

    lead INDUSTRY

Principal Investigators

  • Divya Patel, BSc · Affiliated

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-11
Primary Completion
2017-11-17
Completion
2018-03-15

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03198936 on ClinicalTrials.gov